Hydrogenated phosphatidylcholine supplementation reduces hepatic lipid levels in mice fed a high-fat diet

Atherosclerosis

Volumn 213, Issue 1, 2010, Pages 142-147

  Tandy, Sally ^a   Chung, Rosanna W S ^a   Kamili, Alvin ^a   Wat, Elaine ^a   Weir, Jacquelyn M ^b   Meikle, Peter J ^b   Cohn, Jeffrey S ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Ceramide; Dietary phospholipid; Fatty liver disease; Intestinal cholesterol absorption; Phosphatidylcholine; Sphingomyelin; Steatosis

Indexed keywords

CERAMIDE; CHOLESTEROL; COMPLEMENTARY DNA; LIPID; MESSENGER RNA; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; SPHINGOMYELIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DIETARY INTAKE; ELECTROSPRAY MASS SPECTROMETRY; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; FATTY LIVER; FOOD INTAKE; GENE EXPRESSION; HYDROGENATION; INTESTINE ABSORPTION; LIPID DIET; LIVER METABOLISM; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WEIGHT GAIN;

ANIMAL FEED; ANIMALS; CHOLESTEROL; DIETARY FATS; FATTY LIVER; GENE EXPRESSION REGULATION; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPHINGOMYELINS;

EID: 77958503717     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.050     Document Type: Article

References (23)

1. Cohn J.S., Wat E., Kamili A., Tandy S. Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease. Curr Opin Lipidol 2008, 19:257-262.
2. O'Brien B.C., Corrigan S.M. Influence of dietary soybean and egg lecithins on lipid responses in cholesterol-fed guinea pigs. Lipids 1988, 23:647-650.
3. Iwata T., Hoshi S., Takehisa F., Tsutsumi K., Furukawa Y., Kimura S. The effect of dietary safflower phospholipid and soybean phospholipid on plasma and liver lipids in rats fed a hypercholesterolemic diet. J Nutr Sci Vitaminol (Tokyo) 1992, 38:471-479.
4. Polichetti E., Janisson A., de la Porte P.L., et al. Dietary polyenylphosphatidylcholine decreases cholesterolemia in hypercholesterolemic rabbits: role of the hepato-biliary axis. Life Sci 2000, 67:2563-2576.
5. Knuiman J.T., Beynen A.C., Katan M.B. Lecithin intake and serum cholesterol. Am J Clin Nutr 1989, 49:266-268.
6. Cohn J.S., Kamili A., Wat E., Chung R.W.S., Tandy S. Dietary phospholipids and intestinal cholesterol absorption. Nutrients 2010, 2:116-127.
7. Jiang Y., Noh S.K., Koo S.I. Egg phosphatidylcholine decreases the lymphatic absorption of cholesterol in rats. J Nutr 2001, 131:2358-2363.
8. Noh S.K., Koo S.I. Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats. J Nutr 2004, 134:2611-2616.
9. Eckhardt E.R., Wang D.Q., Donovan J.M., Carey M.C. Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology 2002, 122:948-956.
10. Wat E., Tandy S., Kapera E., et al. Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis 2009, 205:144-150.
11. Tandy S., Chung R.W., Wat E., et al. Dietary krill oil supplementation reduces hepatic steatosis, glycemia and hypercholesterolemia in high-fat-fed mice. J Agric Food Chem 2009, 57:9339-9345.
12. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
13. Siri-Tarino P.W., Sun Q., Hu F.B., Krauss R.M. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 2010, 91:502-509.
14. Jump D.B., Botolin D., Wang Y., Xu J., Christian B., Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr 2005, 135:2503-2506.
15. Mackay K., Starr J.R., Lawn R.M., Ellsworth J.L. Phosphatidylcholine hydrolysis is required for pancreatic cholesterol esterase- and phospholipase A2-facilitated cholesterol uptake into intestinal Caco-2 cells. J Biol Chem 1997, 272:13380-13389.
16. Homan R., Hamelehle K.L. Phospholipase A2 relieves phosphatidylcholine inhibition of micellar cholesterol absorption and transport by human intestinal cell line Caco-2. J Lipid Res 1998, 39:1197-1209.
17. Cohen D.E., Carey M.C. Acyl chain unsaturation modulates distribution of lecithin molecular species between mixed micelles and vesicles in model bile. Implications for particle structure and metastable cholesterol solubilities. J Lipid Res 1991, 32:1291-1302.
18. Plosch T., Kruit J.K., Bloks V.W., et al. Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the Abcg5/8 transporter. J Nutr 2006, 136:2135-2140.
19. Repa J.J., Turley S.D., Quan G., Dietschy J.M. Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption. J Lipid Res 2005, 46:779-789.
20. Ide T., Murata M. Depressions by dietary phospholipids of soybean and egg yolk origins of hepatic triacylglycerol and fatty acid synthesis in fasted-refed rats. Ann Nutr Metab 1994, 38:340-348.
21. Devlin C.M., Leventhal A.R., Kuriakose G., Schuchman E.H., Williams K.J., Tabas I. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler Thromb Vasc Biol 2008, 28:1723-1730.
22. Holland W.L., Brozinick J.T., Wang L.P., et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007, 5:167-179.
23. Billich A., Baumruker T. Sphingolipid metabolizing enzymes as novel therapeutic targets. Subcell Biochem 2008, 49:487-522.